HER2 Expression in Ovarian Mucinous Carcinomas in Tunisia

Determination of HER2 Gene Amplification in Breast Cancer using Dual-color Silver Enhanced in situ Hybridization (dc-SISH) and Comparison with Fluorescence ISH (FISH)

(2014) Betul Unal et al.   Asian Pacific Journal of Cancer Prevention

Detection of HER2 Status in Breast Cancer: Comparison of Current Methods with MLPA and Real-time RT-PCR

(2014) Reza Pazhoomand et al.   Asian Pacific Journal of Cancer Prevention

Association of High LDH and Low Glucose Levels in Pleural Space with HER2 Expression in Non-Small Cell Lung Cancer

(2014) Bijan Ziaian et al.   Asian Pacific Journal of Cancer Prevention

Retrospective Analysis of Neoadjuvant Chemotherapy for Breast Cancer in Turkish Patients

(2013) Berna Bozkurt Duman et al.   Asian Pacific Journal of Cancer Prevention

Impact of HER2 and PTEN Simultaneous Deregulation in Non-small Cell Lung Carcinoma: Correlation with Biological Behavior

(2013) Ioannis Panagiotou et al.   Asian Pacific Journal of Cancer Prevention

Adjuvant Trastuzumab for 6 Months is Effective in Patients with HER2-positive Stage II or III Breast Cancer

(2013) Cheng-Jeng Tai et al.   Asian Pacific Journal of Cancer Prevention

HER2 Amplification and Clinicopathological Characteristics in a Large Asian Cohort of Rare Mucinous Ovarian Cancer

(2013) Wen-Yee Chay et al.   PLoS One

HER2/neu Expression in Head and Neck Squamous Cell Carcinoma Patients is not Significantly Elevated

(2012) Yasaman Sardari et al.   Asian Pacific Journal of Cancer Prevention

Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates

(2012) Ananta Gurung et al.   HISTOPATHOLOGY

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas

(2012) Michael S Anglesio et al.   JOURNAL OF PATHOLOGY

Identification of the Coexisting HER2 Gene Amplification and Novel Mutations in the HER2 Protein-Overexpressed Mucinous Epithelial Ovarian Cancer

(2011) Wea-Lung Lin et al.   ANNALS OF SURGICAL ONCOLOGY

Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma

(2011) S. John Weroha et al.   GYNECOLOGIC ONCOLOGY

Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours

(2011) B. Yan et al.   JOURNAL OF CLINICAL PATHOLOGY

Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006

(2010) Nabiha Missaoui et al.   INTERNATIONAL JOURNAL OF CANCER

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

(2009) Jessica N McAlpine et al.   BMC CANCER

Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer

(2009) Peter J. Frederick et al.   GYNECOLOGIC ONCOLOGY

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma

(2008) Adelaida García-Velasco et al.   Clinical & Translational Oncology

Systematic Review of HER2 Breast Cancer Testing

(2008) Marta Cuadros et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY